Mucoadhesion studies in the gastrointestinal tract to increase oral drug bioavailability;Estudos de mucoadesão no trato gastrointestinal para o aumento da biodisponibilidade oral de fármacos

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 4, 2008, Pages 535-548

  Varum, Felipe Oliveira ^a,b   Basit, Abdul Waseh ^b   Sousa, João ^a   Veiga, Francisco ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Universidade de Londres   (United Kingdom)

Author keywords

Drugs absortion; Drugs oral bioavailability; Gastrointestinal tract mucoadhesion study; Mucoadhesion in vitro and in vivo studies

Indexed keywords

COLON; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG RELEASE; GAMMA SCINTIGRAPHY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HUMAN; INTESTINE MOTILITY; MUCOADHESION; NONHUMAN; REVIEW;

EID: 59649114054     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000400002     Document Type: Review

References (83)

1. ABRAHAMSSON, B.; ALPSTEN, M.; JONSSON, U.E.; LUNDBERG, P.J.; SANDBERG, A.; SUNDGREN, M.; SVENHEDEN, A.; TOLLI, J. Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. Int. J. Pharm., v.140, n.2, p.229-235, 1996.
2. ACCILLI, D.; MENGHI, G.; BONACUCINA, G.; DI MARTINO, P.; PALMIERI, G.F. Mucoadhesion dependence of pharmaceutical polymers on mucosa characteristics. Eur. J. Pharm. Sci., v.22, n.225-234, 2004.
3. ACHAR, L.; PEPPAS, N.A. Preparation, characterization and mucoadhesive interactions of poly(methacrylic acid) copolymers with rat mucosa. J. Control. Release, v.31, p.271-276, 1994.
4. ADKIN, D.A.; DAVIS, S.S.; SPARROW, R.A.; WILDING, I.R. Colonic transit of different sized tablets in healthy subjects. J. Control. Release, v.23, p.147-156, 1993.
5. AHUJA, A.; KHAR, R.K.; ALI, J. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm., v.23, n.5, p.489-515, 1997.
6. AKIYAMA, Y.; NAGAHARA, N.; NARA, E.; KITANO, M.; SUSUMU, I.; YAMAMOTO, I.; AZUMA, J.; OGAWA, Y. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J. Pharm. Pharmacol., v.50, p.159-166, 1998.
7. ATUMA, C.; STRUGALA, V.; ALLEN, A.; HOLM, L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol., v.280, p.922-929, 2001.
8. BASIT, A.W. Advances in colonic drug delivery. Drugs, v.65, n.14, p.1991-2007, 2005.
9. BATCHELOR, H. Bioadhesive dosage forms for esophageal drug delivery. Pharm. Res., v.22, n.2, p.175-181, 2005.
10. BATCHELOR, H.K.; BANNING, D.; DETTMAR, P.W.; HAMPSON, F.C.; JOLLIFFE, I.G.; CRAIG, D.Q.M. An in vitro mucosal model for prediction of the bioadhesion of alginate solutions to the oesophagus. Int. J. Pharm., v.238, p.123-132, 2002.
11. BATCHELOR, H.K.; TANG, M.; DETTMAR, P.W.; HAMPSON, F.C.; JOLLIFFEB, I.G.; CRAIG, D.Q.M. Feasibility of a bioadhesive drug delivery system targeted to oesophageal tissue. Eur. J. Pharm. Biopharm., v.57, p.295-298, 2004.
12. BERNKOP-SCHNURCH, A.; STEININGER, S. Synthesis and characterisation of mucoadhesive thiolated polymers. Int. J. Pharm., v.194, p.239-247, 2000.
13. BERNKOP SCHNURCH, A.; SCHWARZ, V.; STEININGER, S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res., v.16, n.6, p.876-881, 1999.
14. CH'NG, H.S.; PARK, H.; KELLY, P.; ROBINSON, J.R. Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci., v.74, n.4, p.399-405, 1985.
15. CHARY, R.B.R.; VANI, G.; RAO, Y.M. In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm., v.25, n.5, p.685-690, 1999.
16. COPPI, G.; SALA, N.; BONDI, M.; SERGI, S.; IANNUCCELLI, V. Ex-vivo evaluation of alginate microparticles for Polymyxin B oral administration. J. Drug Target., v.14, n.9, p.599-606, 2006.
17. COUPE, A.J.; DAVIS, S.S.; WILDING, I.R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res., v.8, n.3, p.360-364, 1991.
18. DAVIS, S.S. Formulation strategies for absorption windows Drug Discov. Today, v.10, n.4, p.249-257, 2005.
19. DE ASCENTIIS, A.; DEGRAZIA, J.L.; BOWMAN, C.N.; COLOMBO, P.; PEPPAS, N.A. Mucoadhesion of poly(2-hydroxyethyl methacrylate) is improved when linear poly(ethylene oxide) chains are added to the polymer network. J. Control. Release, v.33, n.1, p.197-201, 1995.
20. DEVEREUX, J.E.; NEWTON, J.M.; SHORT, M.B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol., v.42, p.500-1, 1990.
21. DOBROZSI, D.J.; SMITH, R.L.; SAKR, A.A. Comparative mucoretention of sucralfate suspensions in an everted rat esophagus model. Int. J. Pharm., v.189, p.81-89, 1999.
22. EDSMAN, K.; HÄGERSTRÖM, H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J. Pharm. Pharmacol., v.57, p.3-22, 2005.
23. EDWARDS, C. Physiology of the colorectal barrier. Adv. Drug Deliv. Rev., v.28, n.2, p.173-190, 1997.
24. FOLLONIER, N.; DOELKER, E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S.T.P. Pharma Sci., v.2, p.141-158, 1992.
25. GOTO, T.; MORISHITA, M.; KAVIMANDAN, N.J.; TAKAYAMA, K.; PEPPAS, N.A. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. J. Pharm. Sci., v.95, n.2, p.462-469, 2006.
26. GRABOVAC, V.; GUGGI, D.; BERNKOP-SCHNURCH, A. Comparison of the mucoadhesive properties of various polymers. Adv. Drug Deliv. Rev., v.57, p.1713-1723, 2005.
27. HAEBERLIN, B.; FRIEND, D.R. Anatomy and Physiology of the gastrointestinal tract: Implications for colonic drug delivery. In: Friend, D.R. eds. Oral colon-specific drug delivery. Boca Raton: CCR Press, 1992. cap.1, p.2-43.
28. HARDY, J.G. Colonic transit and drug delivery. In: Hardy, J.G., Davis, S.S., Wilson, C.G. eds. Drug delivery to the gastrointestinal tract. New York: Ellis Horwood, 1989. cap.6, p.75-81.
29. HARRIS, D.; FELL, J.T.; SHARMA, H.L.; TAYLOR, D.C. GI transit of potential bioadhesive formulations in man: A scintigraphic study. J. Control. Release, v.12, p.45-53, 1990.
30. HAUPT, S.; ZIONI, T.; GATI, I.; KLEINSTERN, J.; RUBINSTEIN, A. Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancer. Eur. J. Pharm. Sci., v.28, n.3, p.204-211, 2006.
31. HENRIKSEN, I.; GREEN, K.L.; SMART, J.D.; SMISTAD, G.; KARLSEN, J. Bioadhesion of hydrated chitosans: An in vitro and in vivo study. Int. J. Pharm., v.145, n.1-2, p.231-240, 1996.
32. HOSNY, E.A. Formulation and comparative evaluation of bioadhesive containing diclofenac sodium and commercial enteric coated tablets in-vitro and in dogs. Int. J. Pharm., v.133, n.1-2, p.149-153, 1996.
33. JACKSON, S.J.; PERKINS, A.C. In vitro assessment of the mucoadhesion of cholestyramine to porcine and human gastric mucosa. Eur. J. Pharm. Biopharm., v.52, p.121-127, 2001.
34. KAKOULIDES, E.P.; SMART, J.D.; TSIBOUKLIS, J. Azocrosslinked poly(acrylic acid) for colonic delivery and adhesion specificity: in vitro degradation and preliminary ex vivo bioadhesion studies. J. Control. Release, v.54, n.1, p.95-109, 1998.
35. KEELY, S.; RULLAY, A.; WILSON, C.; CARMICHAEL, A.; CARRINGTON, S.; CORFIELD, A.; HADDLETON, D.M.; BRAYDEN, D.J. In vitro and ex vivo intestinal tissue models to measure mucoadhesion of Poly(methacrylate) and N-Trimethylated chitosan polymers. Pharm. Res., v.22, n.1, p.38-49, 2005.
36. KENDALL, R.A.; BASIT, A.W. The role of polymers in solid oral dosage forms. In: UCHEGBU, I.F., SCHÄTZLEIN, A.G. Eds. Polymers in drug delivery. Boca Raton: Taylor and Francis, 2006. cap.6, p.35-48.
37. KHOSLA, R.; DAVIS, S.S. The effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol., v.39, p.47-49, 1987.
38. KRAULAND, A.H.; LEITNER, V.M.; GRABOVAC, V.; BERNKOP SCHNURCH, A. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan. J. Pharm. Sci., v.95, n.11, p.2463-2472, 2006.
39. LEE, J.W.; PARK, J.H.; ROBINSON, J.R. Bioadhesive-based dosage forms: The next generation. J. Pharm. Sci., v.89, p.850-866, 2000.
40. LEHR, C.-M. From sticky stuff to sweet receptors - achievements, limits and novel approaches to bioadhesion. Eur. J. Drug Metab. Pharmacokinet., v.21, n.2, p.139-148, 1996.
41. LEHR, C.-M.; BOUWSTRA, J.A.; SCHACHT, E.H.; JUNGINGER, H.E. in vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm., v.78, p.43-48, 1992.
42. LEHR, C.-M.; BOUWSTRA, J.A.; TUKKER, J.J.; JUNGINGER, H.E. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat - A comparative study with copolymers and blends based on poly(acrylic acid). J. Control. Release, v.13, p.51-62, 1990.
43. LEHR, C.-M.; POELMA, F.G.J.; JUNGINGER, H.E.; TUKKER, J.J. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm., v.70, p.235-240, 1991.
44. LONGER, M.A.; CH'NG, H.S.; ROBINSON, J.R. Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J. Pharm. Sci., v.74, n.4, p.406-411, 1985.
45. MATSUO, K.; OTA, H.; AKAMATSU, T.; SUGIYAMA, A.; KATSUYAMA, T. Histochemistry of the surface mucous gel layer of the human colon. Gut, v.40, n.6, p.782-789, 1997.
46. MCCARGAR, L.; CRAIL, D.; DANSEREAU, R.; MYERS, W.; LANE, M. The in-vitro porcine adhesion model is not predictive of the esophageal transit of risedronate tablets in humans. Int. J. Pharm., v.222, p.191-197, 2001.
47. MCCORD, G.S.; CLOUSE, R.E. Pill-induced esophageal strictures: clinical features and risk factors for development. Am. J. Med., v.88, p.512-518, 1990.
48. MORTAZAVI, S.A. An in vitro assessment of mucus/ mucoadhesive interactions. Int. J. Pharm., v.124, n.2, p.173-182, 1995.
49. MORTAZAVI, S.A.; SMART, J.D. An investigation into the role of water movement and mucus gel dehydation in mucoadhesion. J. Control. Release, v.25, p.197-203, 1993.
50. NAKANISHI, T.; KAIHO, F.; HAYASHI, M. Use of sodium salt of Carbopol 934P in oral peptide delivery. Int. J. Pharm., v.171, n.2, p.177-183, 1998.
51. PARK, K.; ROBINSON, J.R. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int. J. Pharm., v.19, p.107-127, 1984.
52. PEPPAS, N.A.; SALLIN, J.J. Hydrogels as mucoadhesive and bioadhesive materials: A review. Biomaterials, v.17, p.1553-1561, 1996.
53. PREDA, M.; LEUCUTA, S.E. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/ in vivo characterization. J. Microencapsul., v.20, n.6, p.777-789, 2003.
54. PRUDAT-CHRISTIAENS, C.; ARNAUD, P.; ALLAIN, P.; CHAUMEIL, J.C. Aminophylline bioadhesive tablets attempted by wet granulation. Int. J. Pharm., v.141, n.1-2, p.109-116, 1996.
55. RASTOGI, R.; SULTANA, Y.; AQIL, M.; ALI, A.; KUMAR, S.; CHUTTANI, K.; MISHRA, A.K. Alginate microspheres of isoniazid for oral sustained drug delivery. Int. J. Pharm., v.334, n.1-2, p.71-77, 2007.
56. RICHARDSON, J.C.; DETTMAR, P.W.; HAMPSON, F.C.; MELIA, C.D. Oesophageal bioadhesion of sodium alginate suspensions: particle swelling and mucosal retention. Eur. J. Pharm. Sci., v.23, p.49-56, 2004.
57. RÍHOVÁ, B.; RATHI, R.C.; KOPECKOVÁ, P.; KOPECÉK, J. In vitro bioadhesion of carbohydrate containing N-(2-hydroxypropyl)methacrylamide copolymers to the GI tract of guinea pigs. Int. J. Pharm., v.87, p.105-116, 1992.
58. ROUGE, N.; BURI, P.; DOELKER, E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm., v.136, p.117-139, 1996.
59. RUBINSTEIN, A.; TIROSH, B. Mucus gel thickness and turnover in the gastrointestinal tract of the rat: response to cholinergic stimulus and implication for mucoadhesion. Pharm. Res., v.11, n.6, p.794-799, 1994.
60. SÄKKINEN, M.; LINNA, A.; OJALA, S.; JÜRJENSON, H.; VESKI, P.; MARVOLA, M. In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel-forming excipient. Int. J. Pharm., v.250, p.227-237, 2003.
61. SÄKKINEN, M.; MARVOLA, J.; KANERVA, H.; LINDEVALL, K.; AHONEN, A.; MARVOLA, M. Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus. Eur. J. Pharm. Biopharm., v.57, p.145-147, 2004.
62. SANTOS, C.A.; JACOB, J.S.; HERTZOG, B.A.; FREEDMAN, B.D.; PRESS, D.L.; HARNPICHARNCHAI, P.; MATHIOWITZ, E. Correlation of two bioadhesion assays: the everted sac technique and the CAHN microbalance. J. Control. Release, v.61, p.113-122, 1999.
63. SCHILLER, C.; FROHLICH, C.P.; GIESSMANN, T.; SIEGMUND, W.; MÖNNIKES, H.; HOSTEN, N.; WEITSCHIES, W. Intestinal fluid v.umes and transit of dosage forms as assessed by magnetic ressonance imaging. Aliment. Pharmacol. Ther., v.22, p.971-979, 2005.
64. SHIMODA, J.; ONISHI, H.; MACHIDA, Y. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Dev. Ind. Pharm., v.27, n.6, p.567-576, 2001.
65. SMART, J.D. The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev., v.57, p.1556-1568, 2005.
66. SMART, J.D.; KELLAWAY, I.W. Pharmaceutical factors influencing the rate of gastrointestinal transit in an animal model. Int. J. Pharm., v.53, p.79-83, 1989.
67. SMART, J.D.; KELLAWAY, I.W.; WORTHINGTON, H.E.C. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol., v.36, p.295-299, 1984.
68. TAKEUCHI, H.; THONGBORISUTE, J.; MATSUI, Y.; SUGIHARA, H.; YAMAMOTO, H.; KAWASHIMA, Y. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv. Drug Deliv. Rev., v.57, p.1583-1594, 2005.
69. TALUKDER, R.; FASSIHI, R. Gastroretentive delivery systems: A mini review. Drug Dev. Ind. Pharm., v.30, n.10, p.1019-1028, 2004.
70. TAMBURIC, S.; CRAIG, D.Q.M. A comparison of different in vitro methods for measuring mucoadhesive performance. Eur. J. Pharm. Biopharm., v.44, p.159-167, 1997.
71. TOBYN, M.J.; JOHNSON, J.R.; DETTMAR, P.W. Factors affecting in vitro gastric mucoadhesion. I. Test Conditions and instrumental parameters. Eur. J. Pharm. Biopharm., v.41, n.4, p.235-241, 1995.
72. TOBYN, M.J.; JOHNSON, J.R.; DETTMAR, P.W. Factors affecting in vitro gastric mucoadhesion. II. Physical properties of polymers. Eur. J. Pharm. Biopharm., v.42, n.1, p.56-61, 1996.
73. TULEU, C.; ANDRIEUX, C.; BOY, P.; CHAUMEIL, J.C. Gastrointestinal transit of pellets in rats: effect of size and density. Int. J. Pharm., v.180, n.1, p.123-131, 1999.
74. TULEU, C.; BASIT, A.W.; WADDINGTON, W.A.; ELL, P.J.; NEWTON, J. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules. Aliment. Pharmacol. Ther., v.16, p.1771-1779, 2002.
75. UGWOKE, M.I.; AGU, R.U.; VERBEKE, N.; KINGET, R. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv. Drug Deliv. Rev., v.57, p.1640-1665, 2005.
76. VASIR, J.K.; TAMBWEKAR, K.; GARG, S. Bioadhesive microspheres as a controlled drug delivery system. Int. J. Pharm., v.255, p.13-32, 2003.
77. WATTS, P.J.; ILLUM, L. Colonic drug delivery. Drug Dev. Ind. Pharm., v.23, n.9, p.893-913, 1997.
78. WILDING, I.R. Scintigraphic evaluation of colonic delivery systems. S.T.P. Pharma Sci., v.5, n.1, p.13-18, 1995.
79. WILDING, I.R. Site-specific drug delivery in the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Syst., v.17, n.6, p.557-620, 2000.
80. WILDING, I.R.; COUPE, A.J.; DAVIS, S.S. The role of gamma-scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev., v.46, p.103-124, 2001.
81. WITTAYA-AREEKUL, S.; KRUENATE, J.; PRAHSARN, C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int. J. Pharm., v.312, p.113-118, 2006.
82. WOODLEY, J. Bioadhesion: new possibilities for drug administration? Clin. Pharmacokinet., v.40, n.2, p.77-84, 2001.
83. YANG, L.; CHU, J.S.; FIX, J.A. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int. J. Pharm., v.235, p.1-15, 2002.